| Affiliation: | 1. Haematology Department, University College London, UCLH and Whittington Hospitals, UCL Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK;2. Haematology Department, University College London, Cancer Institute, UCL Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6BT, UK;1. Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, 9609 Medical Center Drive, Room 6E516, MSC 9772, Bethesda, MD 20892-9772, USA;2. Commissioned Corps of the US Public Health Service, US Department of Health and Human Services, 330 C Street SW, Washington, DC 20416, USA;1. Division of Clinical Pharmacy, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Drive, MC 0714, La Jolla, CA 92093-0714, USA;2. Division of Hematology/Oncology, Bone Marrow Transplant, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA;3. Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, 2424 Erwin Road, Suite 602, Durham, NC 27705, USA;4. Department of Medicine, UC San Diego Moores Cancer Center, 3855 Health Sciences Drive, MC 0987, La Jolla, CA 92130, USA;1. Laboratory of Hematology, Biology and Pathology Center, CHU of Lille, Lille, France;2. Department of Hematology, Hospital of the Miletrie, INSERM CIC 1402, CHU of Poitiers, Poitiers, France;3. INSERM UMR S 1172, Team 4, Cancer Research Institute, Lille, France |
